Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
Filter
  • inflammation  (2)
  • 1
    Keywords: EXPRESSION ; DISEASE ; liver ; GENE-EXPRESSION ; NF-KAPPA-B ; mechanisms ; C-JUN ; DOWN-REGULATION ; TNF-ALPHA ; inflammation ; INFLAMMATORY-BOWEL-DISEASE ; FACTOR-ALPHA ; MOLECULAR-MECHANISMS ; TRANSCRIPTIONAL ACTIVATION ; STEROID-HORMONE RECEPTORS ; ENDOTOXIC-SHOCK
    Abstract: As glucocorticoid resistance (GCR) and the concomitant burden pose a worldwide problem, there is an urgent need for a more effective glucocorticoid therapy, for which insights into the molecular mechanisms of GCR are essential. In this study, we addressed the hypothesis that TNF alpha, a strong pro-inflammatory mediator in numerous inflammatory diseases, compromises the protective function of the glucocorticoid receptor (GR) against TNF alpha-induced lethal inflammation. Indeed, protection of mice by dexamethasone against TNF alpha lethality was completely abolished when it was administered after TNF alpha stimulation, indicating compromised GR function upon TNF alpha challenge. TNF alpha-induced GCR was further demonstrated by impaired GR-dependent gene expression in the liver. Furthermore, TNF alpha down-regulates the levels of both GR mRNA and protein. However, this down-regulation seems to occur independently of GC production, as TNF alpha also resulted in down-regulation of GR levels in adrenalectomized mice. These findings suggest that the decreased amount of GR determines the GR response and outcome of TNF alpha-induced shock, as supported by our studies with GR heterozygous mice. We propose that by inducing GCR, TNF alpha inhibits a major brake on inflammation and thereby amplifies the pro-inflammatory response. Our findings might prove helpful in understanding GCR in inflammatory diseases in which TNF alpha is intimately involved
    Type of Publication: Journal article published
    PubMed ID: 21646349
    Signatur Availability
    BibTip Others were also interested in ...
  • 2
    Keywords: RECEPTOR ; CELLS ; EXPRESSION ; IN-VITRO ; CELL ; Germany ; VITRO ; DISEASE ; MICE ; TIME ; MACROPHAGES ; SERA ; REDUCTION ; animals ; bone marrow ; BONE-MARROW ; DELETION ; NO ; LESIONS ; DIFFERENCE ; inactivation ; MUSCLE ; ATHEROSCLEROSIS ; DIET ; MOUSE MODEL ; VASCULATURE ; glucocorticoid receptor ; CALCIUM ; BEHAVIOR ; SMOOTH-MUSCLE ; inflammation ; SERUM ; PRODUCTS ; INCREASE ; DEFICIENT MICE ; GC ; methods ; dexamethasone ; USA ; BONE ; animal ; SMOOTH-MUSCLE-CELLS ; smooth muscle cells ; MEDIA ; RANKL ; VASCULAR CALCIFICATION ; MUSCLE-CELLS ; MARROW ; in vitro ; CRUCIAL ROLE ; DRIVEN ; ARTERIAL CALCIFICATION ; CHOLESTEROL-FED RABBITS ; CORONARY ANGIOPLASTY ; KAPPA-B LIGAND ; OSTEOPROTEGERIN ; RECEPTOR ACTIVATOR
    Abstract: Objective - Macrophage-derived products are known to play a crucial role during atherogenesis and vascular calcification. Glucocorticoids (GC) are important modulators of immune cell functions, but their specific effects on macrophages behavior during plaque formation are not defined. The present study was therefore designed to investigate the effects of macrophage-specific deletion of the glucocorticoid receptor (GR(LysMCre)) on atherogenesis and vascular calcification in a hyperlipidemic mouse-model. Methods and Results - Bone marrow was isolated from GRLysMCre mice and wild-type controls (GR(flox)) and subsequently transplanted into lethally irradiated LDL-receptor -deficient mice. Animals were fed a Western-type diet for 15 or 24 weeks, and atherosclerotic lesions within the aortic sinus were evaluated. At both time points, no significant difference in serum lipid and corticosterone concentrations, atherosclerotic lesion size and macrophage-content within the lesions could be observed. However, GRLysMCre mice showed less calcification as well as a significant reduction of RANKL, BMP2, and Msx2 expression within the vasculature. In vitro studies using conditioned media from macrophages which had been stimulated with dexamethasone demonstrated a dose-dependent increase in calcium deposition by vascular smooth muscle cells. Conclusion - This study demonstrates that macrophage-specific glucocorticoid receptor inactivation reduces vascular calcification without affecting atherosclerotic lesion size in LDL receptor -deficient mice. (Arterioscler Thromb Vasc Biol. 2008;28:2158-2164.)
    Type of Publication: Journal article published
    PubMed ID: 18787189
    Signatur Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...